BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37587701)

  • 21. Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report.
    Zhang Y; Deng X; Ding Z; Kang J; Wu B; Guo B; Fan Y
    Medicine (Baltimore); 2021 Mar; 100(12):e25191. PubMed ID: 33761701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma.
    Du W; Shi X; Fang Q; Zhang X; Liu S
    Front Endocrinol (Lausanne); 2022; 13():768028. PubMed ID: 35282451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial.
    Yuan M; Wang Z; Zhang Y; Chen L; Liu Y; Cui C; Sun B
    J Oncol; 2021; 2021():5177140. PubMed ID: 34422049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation between thyroid hormones and renal function in severe pre-eclampsia patients with hypothyroidism].
    Zhou J; Li W; Du J; Qiao C; Shang T; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Nov; 49(11):811-5. PubMed ID: 25603904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer.
    Lin Y; Wang C; Gao W; Cui R; Liang J
    Oncotarget; 2017 Jun; 8(26):42252-42261. PubMed ID: 28178685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis.
    Zhu Y; Liu K; Wang K; Peng L
    Front Endocrinol (Lausanne); 2022; 13():909333. PubMed ID: 35909569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
    Shi L; You Q; Wang J; Wang H; Li S; Tian R; Yao X; Wu W; Zhang L; Wang F; Lin Y; Li S
    Endocrine; 2022 Oct; 78(1):68-76. PubMed ID: 35767182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Metformin on Thyroid-Associated Serum Hormone Levels and Physiological Indexes: A Meta-Analysis.
    Wang J; Gao J; Fan Q; Li H; Di Y
    Curr Pharm Des; 2019; 25(30):3257-3265. PubMed ID: 31533598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid hormone levels and structural parameters of thyroid homeostasis are correlated with motor subtype and disease severity in euthyroid patients with Parkinson's disease.
    Tan Y; Gao L; Yin Q; Sun Z; Man X; Du Y; Chen Y
    Int J Neurosci; 2021 Apr; 131(4):346-356. PubMed ID: 32186220
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of Adrenal Reserve in Patients with Differentiated Thyroid Cancer Receiving Thyroid Hormone Suppression Therapy- case-control Comparative Study.
    Bilginer MC; Tam AA; Faki S; Bestepe N; Dellal FD; Ozdemir D; Topaloglu O; Ersoy R; Cakir B
    Endocr Res; 2023 Feb; 48(1):9-15. PubMed ID: 36524715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
    Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Therapeutic Effect and Influencing Factors of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma.
    Zeng F; Zou B; Chen H; Luo M; Liu W
    J Ultrasound Med; 2023 Aug; 42(8):1769-1777. PubMed ID: 36880705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?].
    Wawrzyn H; Hesch RD
    Med Klin (Munich); 2000 Aug; 95(8):421-8. PubMed ID: 10985062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on patients with a discrepancy between free thyroid hormones and thyrotropin values].
    Hisaoka T; Iino S; Saitoh H; Yoshimura H; Ishikawa N; Momotani N; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1994 Aug; 70(6):563-72. PubMed ID: 7958106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are thyroid function tests too frequently and inappropriately requested?
    Roti E; Gardini E; Magotti MG; Pilla S; Minelli R; Salvi M; Monica C; Maestri D; Cencetti S; Braverman LE
    J Endocrinol Invest; 1999 Mar; 22(3):184-90. PubMed ID: 10219885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
    Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in thyrotropin within the near-normal range are associated with increased triiodothyronine but not increased thyroxine in the pediatric age group.
    Karavani G; Strich D; Edri S; Gillis D
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1471-5. PubMed ID: 24878053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
    Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.